These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25181014)

  • 21. Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease. experience from a Cyprus model and its use as a paradigm for future applications.
    Kolnagou A; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):287-95. PubMed ID: 19814674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
    Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C
    Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting quality of life in children and adolescents with thalassemia in Iraqi Kurdistan.
    Mikael NA; Al-Allawi NA
    Saudi Med J; 2018 Aug; 39(8):799-807. PubMed ID: 30106418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.
    Haghpanah S; Vahdati S; Karimi M
    Hemoglobin; 2017 May; 41(3):169-174. PubMed ID: 28741988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.
    Economou M; Printza N; Teli A; Tzimouli V; Tsatra I; Papachristou F; Athanassiou-Metaxa M
    Acta Haematol; 2010; 123(3):148-52. PubMed ID: 20185899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C in patients with β-thalassemia major. A single-centre experience.
    Triantos C; Kourakli A; Kalafateli M; Giannakopoulou D; Koukias N; Thomopoulos K; Lampropoulou P; Bartzavali C; Fragopanagou H; Kagadis GC; Christofidou M; Tsamandas A; Nikolopoulou V; Karakantza M; Labropoulou-Karatza C
    Ann Hematol; 2013 Jun; 92(6):739-46. PubMed ID: 23412560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of Life (QoL) and the Factors Affecting it in Transfusion-dependent Thalassemic Children.
    Chordiya K; Katewa V; Sharma P; Deopa B; Katewa S
    Indian J Pediatr; 2018 Nov; 85(11):978-983. PubMed ID: 29752583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.
    Al-Khabori M; Bhandari S; Al-Rasadi K; Mevada S; Al-Dhuhli H; Al-Kemyani N; Daar S
    Hemoglobin; 2014; 38(5):365-8. PubMed ID: 25074643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current approach to iron chelation in children.
    Aydinok Y; Kattamis A; Viprakasit V
    Br J Haematol; 2014 Jun; 165(6):745-55. PubMed ID: 24646011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
    Mokhtar GM; Tantawy AA; Adly AA; Ismail EA
    Hemoglobin; 2011; 35(4):382-405. PubMed ID: 21797705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of non-adherence to follow-up visits and deferasirox chelation therapy among jordanian adolescents with Thalassemia major.
    Al-Kloub MI; A Bed MA; Al Khawaldeh OA; Al Tawarah YM; Froelicher ES
    Pediatr Hematol Oncol; 2014 Oct; 31(7):624-37. PubMed ID: 25116329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality Matters - Hematopoietic Stem Cell Transplantation versus Transfusion and Chelation in Thalassemia Major.
    Patel S; Swaminathan VV; Mythili VS; Venkatadesikalu MS; Sivasankaran M; Jayaraman D; Balasubramaniam R; Uppuluri R; Raj R
    Indian Pediatr; 2018 Dec; 55(12):1056-1058. PubMed ID: 30745477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and complication rates in patients with thalassemia major in Taiwan.
    Wu HP; Lin CL; Chang YC; Wu KH; Lei RL; Peng CT; Weng T; Tai YM; Chao YH
    Pediatr Blood Cancer; 2017 Jan; 64(1):135-138. PubMed ID: 27571924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of Life in Children with Thalassemia and their Caregivers in India.
    Sharma S; Seth B; Jawade P; Ingale M; Setia MS
    Indian J Pediatr; 2017 Mar; 84(3):188-194. PubMed ID: 27924466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A; Vitrano A; Capra M; Cuccia L; Gagliardotto F; Filosa A; Magnano C; Rizzo M; Caruso V; Gerardi C; Argento C; Campisi S; Cantella F; Commendatore F; D'Ascola DG; Fidone C; Ciancio A; Galati MC; Giuffrida G; Cingari R; Giugno G; Lombardo T; Prossomariti L; Malizia R; Meo A; Roccamo G; Romeo MA; Violi P; Cianciulli P; Rigano P
    Blood Cells Mol Dis; 2009; 42(3):247-51. PubMed ID: 19233692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coenzyme Q10 levels in β-thalassemia and its association with ferritin levels and chelation therapy.
    Karakukcu C; Karakukcu M; Unal E; Patiroglu T; Ozdemir MA; Torun YA; Tang PH
    Hemoglobin; 2012; 36(3):219-29. PubMed ID: 22483337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study on parental stress and behavioral adjustment to the thalassemia major disease process in children undergoing iron-chelation in western Taiwan.
    Kuo HT; Peng CT; Tsai MY
    Hemoglobin; 2006; 30(2):301-9. PubMed ID: 16798655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study.
    García-Mayor RV; Andrade Olivie A; Fernández Catalina P; Castro M; Rego Iraeta A; Reparaz A
    Horm Res; 1993; 40(5-6):189-93. PubMed ID: 8112718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study.
    Scalone L; Mantovani LG; Krol M; Rofail D; Ravera S; Bisconte MG; Borgna-Pignatti C; Borsellino Z; Cianciulli P; Gallisai D; Prossomariti L; Stefàno I; Cappellini MD
    Curr Med Res Opin; 2008 Jul; 24(7):1905-17. PubMed ID: 18507891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.